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New findings by Hughes et al. (2008), Hutcheson et al. (2008), and Weant et al. (2008) highlight the roles of
apoptosis regulators Bim and Fas in the contraction phase of T cell responses and reveal consequences
of failure of this process.If the immune system were a television
game show, the announcer might sum-
marize the rules at the outset in this ab-
breviated way: ‘‘You know how we play:
Each lymphocyte contestant recognizes
a different antigenic determinant, and if
they find it, they proliferate to make the
most effective immune response to win
the game. And that’s all there is to it!’’
But real life is not reality TV, and a funda-
mental, if simple, problem with this ‘‘con-
test’’ quickly reveals itself—the expansion
of lymphocytes in a few immune re-
sponses will overrun the system, preclud-
ing subsequent responses to new anti-
gens, unless they can die rapidly enough
to clear the way. And to make matters
worse, any elicited responses that have
an autoimmune component will wreak
havoc. Now, three papers in this issue of
Immunity (Hughes et al., 2008; Hutcheson
et al., 2008; Weant et al., 2008) give us
some idea of how catastrophic a failure
to clear routine immune responses canbe.
The rise and fall of an immune response
is exemplified by the well-documented
phenomenon of T cell clonal contraction,
also called peripheral deletion. Numbers
of responding T cells increase dramati-
cally, peak, and then decline quickly (of-
ten at a point presumed to reflect removal
of antigen), leaving a relatively small num-
ber of memory T cells. With an earlymodel
for such clonal contraction, it was found
that defects in the death receptor, CD95(Fas), and its ligand CD95-L (FasL), can
play roles in this process (reviewed in
Green et al., 2003), a finding that initially
seemed to agreewith several other obser-
vations: (1) Mice or humans with defects
in either Fas ligand or its receptor have
a marked lymphoaccumulation and often
have accelerated autoimmune disease
(Rieux-Laucat et al., 2003), (2) activation-
induced cell death in T cells, as a conse-
quence of restimulation of a previously
activated T cell, can be due to Fas-FasL
interactions (reviewed in Green et al.,
2003), and (3) although apoptosis by this
mechanismwas the only form understood
at the time, introduction of a Bcl2 trans-
gene (known to block apoptosis in some
settings) expressed in T cells made the
lymphoaccumulation much worse (Reap
et al., 1995).
It emerged, however, that there were
a number of problems with this view.
Bcl-2 (and other antiapoptotic members
of this family) inhibits the mitochondrial
pathway of apoptosis, which is only
sometimes important in death receptor
(such as Fas)-mediated cell death and ap-
pears to have little or no role in Fas-medi-
ated T cell death (Strasser et al., 1995).
Further, the expansion of T cells in mice
or humans lacking functional Fas or FasL
is predominantly that of an unusual subset
(B220+, CD3+, CD4, CD8) that does not
arise in normal immune responses. But
perhaps most importantly, the processImmunitof peripheral deletion was found to be
far more dependent on the proapoptotic
Bcl-2 family protein Bim, than on the death
receptor, Fas (Hildeman et al., 2002). Bim
is a trigger of the mitochondrial pathway
of apoptosis and plays a prominent role
in cell death caused by cytokine depriva-
tion of T cells. Therefore, clonal contrac-
tion of T cells during an immune response
appeared to be apoptosis due to limited
growth and survival factors, rather than
an active ligation of death receptors.
Three papers in this issue of Immunity
(Hughes et al., 2008; Hutcheson et al.,
2008; Weant et al., 2008) now help to re-
solve this. Mice deficient in both Fas func-
tion and Bim have normal development
(including lymphoid development) but
over time display enormous expansion
of lymphoid (and some myeloid) cells.
This includes profound increases in
memory T cell pools (both central and
effector), as well as B cells and macro-
phages. The B220+, CD3+ T cell subset
seen in Fas-defective individuals was
also greatly expanded. Stunningly, lym-
phoid organs in these mice can expand
to represent half of themass of the animal.
Clearly, this is an example of redun-
dancy in a cell-death process, but who
is backing up whom? Bim is a critical
player in the apoptotic response to dep-
rivation from survival factors, especially
in hematopoietic cells, and accumulates
under these conditions to engage they 28, February 2008 ª2008 Elsevier Inc. 141
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PreviewsFigure 1. Bim and Fas Function in the Regulation of Lymphocyte Numbers
During immune responses, dendritic cells (purple stars) induceT cell activation and expansion. If the antigen is rapidly cleared (Scenario 1), survival factors from the
tissue and from the T cells themselves become limited, and, as a consequence, T cells accumulate Bim and the cells die in a Bim-dependent manner. If antigen
persists, however, T cellsmight receive successive activation, resulting in increased survival factors and expression of FasL. The latter engages Fas on both T cells
and dendritic cells, resulting in cell death. If sufficiently extensive, the resulting clonal contraction will be unaffected by changes in Bim function (Scenario 2).
Often, however, the Fas-dependent killing of dendritic cells acts to eliminate residual antigen, and the remaining T cells die in a manner that is, again, Bim
dependent (Scenario 3). Studies in this issue (Hughes et al., 2008; Weant et al., 2008) show that most situations relate to Scenario 3, although acute infection
can produce the situation in Scenario 1. Scenario 2 is consistent with results from others (e.g., Razvi et al., 1995). Excessive expansion of B cells and activated
macrophages in mice defective in Bim and Fas (Hutcheson et al., 2008) could be either a secondary consequence of the T cell expansion or might indicate roles
for Fas and Bim in controlling numbers of these cells in an autonomous fashion.mitochondrial pathway of apoptosis. It
has no known role (or is likely to) in the
apoptotic response to Fas ligation, even
when that pathway relies on the mito-
chondrial pathway.
With respect to the unusual B220+,
CD3+ T cells, it seems likely that these
are usually eliminated by Fas-FasL inter-
actions, and as they expand and survival
factors become limiting, they become
susceptible to Bim-mediated cell death.
It was recognized many years ago that
the expanded lymph node cells in Fas-de-
fective animals readily undergo apopto-
sis upon in vitro culture. This might also
be true of conventional T cells, as well;
T cell-specific deletion of Fas in mice re-
sulted in accumulation of memory T cells
(Hao et al., 2004), although not to any-
where near the numbers of those seen in
the Bim-null, Fas-deficient animals. The
study on T cell-specific Fas deletion was
probably confounded by the upregulation
of FasL on these cells, in turn triggering
death in many of the wild-type cells
needed for T cell expansion (e.g., dendritic
cells). Indeed, dendriticcells lackingFasor
expressing an inhibitor of caspases show
improved T cell-stimulatory activity (Chen
et al., 2006), and at least the latter can pre-
dispose animals to autoimmunity. We will
come back to this useful hint below.142 Immunity 28, February 2008 ª2008 ElseTwostudies in this issueaddressperiph-
eral deletion in T cells and conclude that
both Bim and Fas signaling can contribute
to thiscell-deathprocess.Hughesandcol-
leagues (2008) distinguished between re-
sponses to two typesof infection. Anacute
infection (HSV-1KOS) resulted in Bim-de-
pendent T cell clonal contraction with no
apparent contribution from Fas, whereas
a more chronic infection (MHV-68) led
to contraction resulting from both Bim-
and Fas-mediated effects. Weant et al.
(2008), however, found that another rela-
tively acute infection (LCMV Armstrong)
led to clonal contraction in which Bim
and Fas both played important roles, and
defects in both resulted in dramatically
enhanced numbers of memory T cells.
So what is going on here? Why is the
function of Fas in clonal contraction so
capricious? I suspect that the key is in the
way in which antigen presentation is con-
trolled in each setting (Figure 1). If antigen
presented on dendritic cells quickly be-
comes limiting as the infection is cleared
(this might apply to HSV-1 Kos infection),
then survival factors and their receptors
also quickly become limiting, andBim-de-
pendent apoptosis is both necessary and
sufficient to reduce cell numbers. How-
ever, when the antigen persists and T cells
continue to respond and generate suchvier Inc.survival factors (and express the recep-
tors), they thereby avoid accumulating
Bim and do not die. But the activated
T cells (and other tissues in the vicinity
of activated T cells (reviewed in Green
et al., 2003) also express FasL, which
can not only kill the T cells themselves,
but will also kill dendritic cells with which
they interact. The result of the latter will
again limit the antigen presentation that
provides survival-factor signaling in the
T cells, and Bim-mediated apoptosis en-
sues. Alternatively, the Fas-mediated kill-
ing can dominate the effect, so that Bcl-2
(and presumably Bim deficiency) does not
prevent the death, which was observed in
another setting involving LCMV (Razvi
et al., 1995). The relative contributions
of Fas-mediated T cell death versus
dendritic cell death (and Bim-mediated
T cell death) might be relatively low in
many cases, thus accounting for why
Bim is so important in the process. Spe-
cific deletions of Bim in T cells versus
dendritic cells will be especially informa-
tive in exploring this aspect of immune
regulation.
Importantly, failure to control lympho-
cyte number in Bim-Fas-defective ani-
mals leads to severe disease resembling
systemic lupus erythematosus (Hughes
et al., 2008; Hutcheson et al., 2008).
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and can die in a Bim-dependent manner,
it is tempting to suggest that both Bim
and Fas play crucial roles in regulating B
cell numbers via cell autonomous pro-
cesses. B cell-specific deletion of Fas
led to accumlation of lymphocytes (to
the same extent as seen in T cell- plus B
cell-specific deletion—although in the B
cell-specific case, without expansion of
the B220+CD3+ T cells), suggesting that
Fas-mediated B cell death plays a role in
the regulation of B cell numbers. The rela-
tive contribution of T cells or B cells lack-
ing Fas signaling to disease is difficult to
assess for the reasons mentioned above,
however, because the defective T cells
show enhanced expression of FasL.
To fully understand the complex inter-
play between these modes of cell death
in the control of lymphocyte numbers,
what we need, it seems, is a way to spe-
cifically block Fas signaling in a specific
cell type while eliminating the effects of
Bim in the same or different cell. But there
is a problem; Fas signals via an adaptor
molecule, FADD, and an initiator caspase,
caspase-8, and elimination of either of
these impacts the ability of the T cell to
activate and/or proliferate (reviewed inThe Importance o
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How critical is it for T cells to stably
(2008) demonstrate profound effe
antigen-presenting cells lacking int
It has become apparent that the stable
interaction of T cells with antigen-present-
ing cells (APCs) is not simply dictated by
the presence of peptide-MHC (pMHC)
complexes on the stimulating APCs.
In vivo, T cells often circle for many hours,
loosely engaging in transient interactions
with APCs before arresting to form stablePellegrini et al., 2005). How this occurs,
and whether we can interfere with the
death pathway while sustaining the acti-
vation pathway mediated by these mole-
cules, is not yet known (but there are hints
that the answer is yes, we can). But per-
haps the important message is that this
pathway plays two roles, positive and
negative, in the control of lymphocyte
number. A T cell that loses Fas upregu-
lates FasL to kill other cells (and dies as
survival factors become limiting). If in-
stead it loses Fas signaling (FADD, or cas-
pase-8) it does not effectively expand.
Loss of Bim allows the cell to survive
under limiting conditions, but these cells
are nevertheless killed by Fas signaling
(or are at least limited by a Fas-dependent
process, such as killing of dendritic
cells).
One autoreactive T lymphocyte, with
unchecked capability for expansion, can
kill the organism. That’s why the game of
T cell survival is so hard to win.
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that peaks synchronously with the period
of time when T cells stably arrest on the
DCs in vivo. In vitro, they subsequently
demonstrated the expected result that
ICAM-1-deficient DCs are defective in
mediating prolonged T cell engagements.
Such a result is, in effect, a modern ver-
sion of lymphocyte-function-associated
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